ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,792 | -87.9% | 494 | -81.9% | 0.00% | – |
| Q2 2023 | $485,033 | +12.4% | 2,722 | +4.1% | 0.00% | – |
| Q1 2023 | $431,535 | +24.8% | 2,616 | +19.2% | 0.00% | – |
| Q4 2022 | $345,669 | -7.8% | 2,195 | -11.9% | 0.00% | – |
| Q3 2022 | $375,000 | -77.7% | 2,491 | -75.7% | 0.00% | -100.0% |
| Q2 2022 | $1,684,000 | -87.7% | 10,245 | -83.4% | 0.00% | -75.0% |
| Q1 2022 | $13,711,000 | +55.0% | 61,583 | +65.2% | 0.00% | +100.0% |
| Q4 2021 | $8,845,000 | -77.6% | 37,271 | -78.0% | 0.00% | -77.8% |
| Q3 2021 | $39,469,000 | +41.9% | 169,120 | +25.1% | 0.01% | +50.0% |
| Q2 2021 | $27,823,000 | +10.2% | 135,194 | +10.0% | 0.01% | 0.0% |
| Q1 2021 | $25,241,000 | +37.4% | 122,862 | +43.5% | 0.01% | +50.0% |
| Q4 2020 | $18,367,000 | +20.7% | 85,631 | +2.9% | 0.00% | 0.0% |
| Q3 2020 | $15,211,000 | +8.7% | 83,235 | +9.6% | 0.00% | 0.0% |
| Q2 2020 | $13,995,000 | -81.6% | 75,937 | -79.8% | 0.00% | -84.6% |
| Q1 2020 | $75,929,000 | +6.1% | 376,321 | -1.6% | 0.03% | +36.8% |
| Q4 2019 | $71,558,000 | +28.6% | 382,413 | +9.7% | 0.02% | +18.8% |
| Q3 2019 | $55,634,000 | -47.3% | 348,585 | -16.8% | 0.02% | -46.7% |
| Q2 2019 | $105,522,000 | +48.9% | 418,889 | +41.5% | 0.03% | +42.9% |
| Q1 2019 | $70,849,000 | -22.4% | 296,033 | -25.5% | 0.02% | -30.0% |
| Q4 2018 | $91,252,000 | -36.5% | 397,389 | -21.8% | 0.03% | -26.8% |
| Q3 2018 | $143,595,000 | +11.3% | 507,855 | +15.6% | 0.04% | +7.9% |
| Q2 2018 | $129,063,000 | +11.9% | 439,508 | -3.8% | 0.04% | +11.8% |
| Q1 2018 | $115,363,000 | +17.1% | 457,064 | +0.2% | 0.03% | +21.4% |
| Q4 2017 | $98,494,000 | -5.5% | 455,999 | -18.7% | 0.03% | -12.5% |
| Q3 2017 | $104,217,000 | +8.7% | 560,756 | +0.9% | 0.03% | +3.2% |
| Q2 2017 | $95,861,000 | +34.8% | 555,712 | +19.3% | 0.03% | +34.8% |
| Q1 2017 | $71,133,000 | +34.0% | 465,840 | +29.3% | 0.02% | +21.1% |
| Q4 2016 | $53,086,000 | +50.4% | 360,270 | +29.0% | 0.02% | +46.2% |
| Q3 2016 | $35,300,000 | +29.5% | 279,316 | +15.6% | 0.01% | +18.2% |
| Q2 2016 | $27,254,000 | +69.6% | 241,724 | +56.6% | 0.01% | +83.3% |
| Q1 2016 | $16,065,000 | +192.9% | 154,324 | +217.3% | 0.01% | +200.0% |
| Q4 2015 | $5,485,000 | +28.1% | 48,629 | +24.3% | 0.00% | 0.0% |
| Q3 2015 | $4,283,000 | -8.7% | 39,118 | -20.2% | 0.00% | 0.0% |
| Q2 2015 | $4,690,000 | -87.2% | 49,020 | -87.5% | 0.00% | -71.4% |
| Q1 2015 | $36,554,000 | +167.8% | 392,480 | +135.5% | 0.01% | +40.0% |
| Q4 2014 | $13,648,000 | +11.2% | 166,643 | -12.8% | 0.01% | 0.0% |
| Q3 2014 | $12,268,000 | +2.1% | 191,144 | -3.3% | 0.01% | 0.0% |
| Q2 2014 | $12,019,000 | -1.9% | 197,645 | -3.4% | 0.01% | 0.0% |
| Q1 2014 | $12,250,000 | +1.7% | 204,589 | +8.3% | 0.01% | 0.0% |
| Q4 2013 | $12,041,000 | +62.0% | 188,988 | +72.8% | 0.01% | +25.0% |
| Q3 2013 | $7,431,000 | -4.1% | 109,398 | +1.8% | 0.00% | 0.0% |
| Q2 2013 | $7,745,000 | – | 107,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |